- $195.80m
- $22.65m
- CH₣27.31m
- 48
- 44
- 51
- 45
Annual balance sheet for AC Immune SA, fiscal year end - December 31st, CHF millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 226 | 198 | 123 | 103 | 165 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1.92 | 1.4 | 0.8 | 15.7 | 2.2 |
| Prepaid Expenses | |||||
| Total Current Assets | 232 | 203 | 128 | 125 | 172 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 6.64 | 8.03 | 7.07 | 6.88 | 8.09 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Total Assets | 239 | 261 | 186 | 183 | 231 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 14 | 20 | 11.5 | 13.6 | 101 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 23.3 | 29.5 | 16.9 | 22.2 | 119 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 215 | 232 | 169 | 161 | 112 |
| Total Liabilities & Shareholders' Equity | 239 | 261 | 186 | 183 | 231 |
| Total Common Shares Outstanding |